PROC: Procaps Company Aggregate Debts

Symbol and logo of brand Procaps Group (PROC)

Procaps Group S.A. (PROC) relies on the supply of gelatin capsules for the Latin American market, where long-term B2B contracts ensure a steady cash flow. The efficiency of the CDMO model increases at full capacity utilization, which minimizes unit costs. Partnerships with industry leaders guarantee revenue stability. The price history of a specific debt instrument, where the indicator is 0.00, confirms the predictability of the company's financial flows.

Procaps Group S.A. - PROC Company Debts (period 07/04/2022 - 02/16/2025)
Original product of Procaps Group

This indicator measures the aggregate credit load, allowing for real-time tracking of bond redemption dynamics and the utilization of bank lines to assess financial stability. By analyzing the aggregate debt structure, an investor can evaluate the ability of Procaps Group S.A. (PROC) to maintain its leadership in Latin America and expand softgel capsule exports without risking insolvency during a period of tight monetary policy.

Analysis of competing companies

Aggregate Debt Obligations Haleon Corp (HLN)|Company Aggregate Debts KVUE (Kenvue Inc.)|veronapharma.com - Company Aggregate Debts|Company Debts Jyong Biotech (MENS)|LGND: Aggregate Debt Obligations|AMRX (Amneal Pharmaceuticals Inc) - Company Debts|Perrigo Corp (PRGO) - Company Total Debt|ALVO (Alvotech) - Company Aggregate Debts|Company Aggregate Debts liquidia.com (LQDA)|Galapagos (GLPG) - Company Total Debt|Aggregate Debt Obligations ANIP (ANI Pharmaceuticals Inc)|MNKD: Company Debts|AMPH - Company Cumulative Debt|Company Total Debt Pacira BioSciences PCRX|SPRY - Company Cumulative Indebtedness|Company Aggregate Debts Theravance Biopharma, Inc. TBPH|Aquestive Therapeutics Inc (AQST) - Aggregate Debt Obligations|Company Aggregate Debts SCPH (scPharmaceuticals, Inc.)|Company Cumulative Debt TECX|Tonix Pharmaceuticals (TNXP) - Company Debts|Aggregate Debt Obligations SXTC (sxtchina.com)|Eupraxia Pharmaceuticals Inc. (EPRX) - Company Debts|BioHarvest Sciences, Inc. - Company Aggregate Indebtedness|Company Debts Invizyne Technologies, Inc. (EXOZ)|ORMP: Aggregate Debt Obligations|Company Debts ENTX|ipatherapeutics.com (HYFT) - Company Cumulative Debt|Company Aggregate Debts ABVC|Company Total Debt Cumberland Pharmaceuticals Inc|Company Aggregate Debts QNTM|Company Aggregate Debts FGEN (FibroGen Corporation)|Telomir Pharmaceuticals (TELO) - Company Debts|Rani Therapeutics Holdings - Company Aggregate Indebtedness|Company Debts SNYR (Synergy CHC Corporation)|Rallybio Corporation (RLYB) - Company Total Debt Obligations|Company Total Debt lexariabioscience.com LEXX|Pulmatrix Corporation (PULM) - Aggregate Debt Obligations|Pheton Holdings Limited - Company Aggregate Debts|Company Total Indebtedness APM|Lyra Therapeutics (LYRA) - Company Debts|Aggregate Debt Obligations IBO (Impact BioMedical, Inc.)|TNFA: Company Debts|YCBD - Company Cumulative Debt|PainReform Ltd. - Company Total Debt|CYTO: Company Aggregate Debts|Company Debts Lipella Pharmaceuticals, Inc. (LIPO)|Company Aggregate Indebtedness OptiNose Inc|PIRS - Company Total Debt|Aggregate Debt Obligations PTPI|QLI (Qilian International) - Company Debts|Company Total Debt Obligations acelyrin.com SLRN|Company Total Debt TFFP